市場調査レポート
商品コード
1379198
医薬品用キャップ・クロージャー市場:製品別、材料別、エンドユーザー別、地域別、2023-2028年Pharmaceutical Caps and Closures Market Report by Product, Material, End User (Pharmaceutical and Biotechnology Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
医薬品用キャップ・クロージャー市場:製品別、材料別、エンドユーザー別、地域別、2023-2028年 |
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
医薬品用キャップ・クロージャーの世界市場規模は2022年に34億米ドルに達しました。今後、IMARC Groupは、2022~2028年の成長率(CAGR)は9.0%を示し、2028年には57億米ドルに達すると予測しています。がん、糖尿病、喘息、心血管疾患などの慢性疾患や急性疾患の有病率の増加、安全で効果的な包装に対するニーズの高まり、小児用包装ソリューションのイントロダクションなどが市場を牽引する主な要因です。
医薬品用キャップ・クロージャーは、ほこりや湿気、好ましくない気候条件から医薬品を保護する気密性の高い密封製品です。さまざまな金属材料や高密度ポリプロピレン(HDPP)、ポリエチレンなどのポリマーで構成されています。環境や微生物による腐敗から製品を保護することで、内容物の鮮度を長期間保つことができます。また、製品の美観を高め、ある場所から別の場所へ輸送する際の取り扱いを便利にします。さらに、微生物による攻撃や汚染の可能性を回避することで、無駄を最小限に抑え、包装された医薬品の保存期間を延ばすことができます。その結果、医薬品用キャップ・クロージャーの需要は世界中で増加しています。
座りがちなライフスタイル、老年人口の増加、不健康な食事パターンにより、高血圧、糖尿病、喘息、肥満、COPD、筋骨格系障害、歯の問題など、様々な急性および慢性疾患の有病率が増加しています。これは、世界中でキャップやクロージャーのような医薬品包装ソリューションの需要を喚起している主な要因の1つです。安全で効果的な包装ソリューションに対する需要の高まりも、医薬品用キャップ・クロージャー市場の技術革新を後押ししています。これとともに、子供の誤飲を防ぐためのチャイルドプルーフ包装ソリューションに対するニーズの高まりも、市場の成長を支える大きな要因となっています。さらに、個人の支出能力の増加や、病院、外来手術センター(ASC)、その他のヘルスケアセンターの拡大に伴い、医薬品に対する需要が世界的に増加しています。さらに、高精度で効率的な軽量キャップ・クロージャーの製造に高度な製造技術を活用することに業界投資家の関心が高まっており、市場の見通しは良好です。これとは別に、プラスチックで製造されたキャップ・クロージャーは、経済的で耐久性があり、腐食に強いため、製薬業界で絶大な支持を得ています。さらに、新興国市場の大手企業は、エンドユーザーの要件を満たすために、耐薬品性に優れたさまざまな形状やサイズのカスタマイズ製品を開拓しています。また、環境への影響や製品開拓コストを削減するため、リサイクル可能な材料や生分解性材料から作られた持続可能なクロージャーソリューションの開発にも注力しており、市場の成長を促進すると予想されます。
The global pharmaceutical caps and closures market size reached US$ 3.4 Billion in2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028 exhibiting a growth rate (CAGR) of 9.0% during 2022-2028. The growing prevalence of chronic and acute conditions, such as cancer, diabetes, asthma, and cardiovascular diseases, rising need for safe and effective packaging, and the introduction of child-proof packaging solution represent some of the key factors driving the market.
Pharmaceutical caps and closures are air-tight sealing products that protect pharmaceutical items from dust, moisture, and unfavorable climatic conditions. They are made up of different metallic materials and polymers, such as high-density polypropylene (HDPP) and polyethylene. They help keep the content fresh for an extended period by protecting products from environmental and microbiological spoilage. They also enhance product aesthetics and make handling convenient during transportation from one place to another. In addition, they assist in minimizing wastage and increasing the shelf-life of packed medicines by averting the chances of microbial attacks and contamination. As a result, the demand for pharmaceutical caps and closures is increasing across the globe.
Due to sedentary lifestyles, rising geriatric population, and unhealthy dietary patterns, there is an increase in the prevalence of various acute and chronic conditions, such as hypertension, diabetes, asthma, obesity, COPD, musculoskeletal disorders, and dental problems. This represents one of the key factors catalyzing the demand for pharmaceutical packaging solutions like caps and closures across the globe. The escalating demand for safe and effective packaging solutions is also encouraging innovations in the pharmaceutical caps and closures market. Along with this, the rising need for child-proof packaging solutions to prevent kids from accidental consumption is another major factor supporting the growth of the market. Furthermore, the demand for pharmaceutical products is increasing worldwide with the increasing expenditure capacity of individuals and the expansion of hospitals, ambulatory surgical centers (ASCs), and other healthcare centers. Moreover, rising focus of industry investors on utilizing advanced manufacturing techniques for producing lightweight caps and closures with high precision and efficiency is offering a favorable market outlook. Apart from this, caps and closures manufactured with plastic are gaining immense traction in the pharmaceutical industry as they are economical, durable, and resistant to corrosion. Furthermore, leading market players are developing customized products in different shapes and sizes with superior chemical resistance properties to meet end-user requirements. They are also focusing on the development of sustainable closure solutions made from recyclable or biodegradable materials to reduce the environmental impact and product development costs, which is anticipated to propel the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical caps and closures market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, material, and end user.
Screw-on Caps
Dispensing Caps
A detailed breakup and analysis of the pharmaceutical caps and closures market based on the product has also been provided in the report. This includes screw-on caps and dispensing caps.
PP
HDPE
LDPE
The report has provided a detailed breakup and analysis of the pharmaceutical caps and closures market based on the material. This includes PP, HDPE, and LDPE.
Pharmaceutical and Biotechnology Companies
Contract Manufacturing Organizations (CMO)
Contract Research Organizations (CRO)
Academic and Research Institutes
A detailed breakup and analysis of the pharmaceutical caps and closures market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, contract manufacturing organizations (CMO), contract research organizations (CRO), and academic and research institutes.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for pharmaceutical caps and closures on account of the highly advanced and robust healthcare infrastructure, presence of well-established pharmaceutical industry, increasing investment in the healthcare industry, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global pharmaceutical caps and closures market. Detailed profiles of all major companies have been provided. Some of the companies covered include Amcor PLC, Aptar Group Inc., Bericap GmbH and Co. KG, Berry Global Group Inc., Closure Systems International Inc., Comar LLC, MJS Packaging, Pano Cap Canada Ltd, Saudi Basic Industries Corporation (Saudi Arabian Oil Co.), Tecnocap S.p.A., United Caps Luxembourg S.A., etc. Kindly note that this only represents a partial list of companies and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.